Every material Form 8-K Microbot Medical Inc. has filed with the SEC since October 23, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Microbot Medical announced that the Canadian Intellectual Property Office granted it a patent for an adaptor that couples a surgical tool such as a guidewire or microcatheter to a motorized robotic surgical device. The company now holds 45 issued patents and 48 patent applications worldwide, including 21 issued patents in North America. The filing contains no financial results, and it does not quantify any effect on sales or revenue.
Canadian Intellectual Property Office granted the patent, announced November 5, 2026
Company holds 45 issued patents and 48 patent applications worldwide as of November 5, 2026
21 of the issued patents are in North America
Company says the patent supports potential future market expansion and regulatory pursuits in additional markets
On October 27, 2026, Microbot Medical announced that ELMNT IR, a multisite outpatient interventional radiology practice in California, signed an order to purchase up to a 12-month supply of LIBERTY devices. ELMNT IR is the first Office-Based Laboratory customer in the world to use the system and the company's first West Coast customer, which the company says supports its push into outpatient settings. The filing does not disclose the order's value or unit count.
ELMNT IR signed an order to purchase up to a 12-month supply of LIBERTY devices, announced October 27, 2026.
ELMNT IR is the first Office-Based Laboratory customer in the world to use the LIBERTY Endovascular Robotic System.
It is Microbot Medical's first customer on the West Coast.
The filing does not state the order's dollar value or number of units.
Microbot Medical said key executives and its commercial team will attend the SIR EDGE 2026 conference in Louisville, Kentucky, from October 25 to 27, 2026, to meet prospective hospital customers for its LIBERTY robotic system. The filing is a routine event announcement and contains no financial results, guidance, or sales figures.
SIR EDGE 2026 conference in Louisville, Kentucky, runs October 25-27, 2026.
The company says the concurrent ACIR Annual Fall Conference offers access to hospital and health network decisionmakers.
Management says the event is intended to set up demonstrations and advance the sales process, including Value Analysis Committee reviews.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Microbot Medical Inc. filing is on SEC EDGAR ↗. 8-K briefs of other companies →